quinacrine has been researched along with Granulocytic Leukemia, Chronic in 1 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Changchien, JJ | 1 |
| Chen, YJ | 1 |
| Huang, CH | 1 |
| Cheng, TL | 1 |
| Lin, SR | 1 |
| Chang, LS | 1 |
1 other study available for quinacrine and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Quinacrine induces apoptosis in human leukemia K562 cells via p38 MAPK-elicited BCL2 down-regulation and suppression of ERK/c-Jun-mediated BCL2L1 expression.
Topics: Antineoplastic Agents; Apoptosis; bcl-X Protein; Cell Survival; Dose-Response Relationship, Drug; Do | 2015 |